REDFLAG

Karen Whitfield

High concern
Age and Gender73, Female
LocationNew York, NY
InsuranceMedicare Fee-For-Service
Provider SeenEddie Torreloma, NP
Medical Record NumberMRN100296
Visits BetweenFeb 3, 2024 – Jan 14, 2025
Date of BirthJul 2, 1951
Age Group65–74
Sex at BirthFemale
RaceBlack or African American
EthnicityNot Hispanic or Latino
Coverage PeriodJan 1, 2024 – Dec 31, 2025
Back to Patients
12Visits(Average 8)
100%Visits with a flag raised(Average 37%)
92%Telehealth visits(Average 64%)
12Controlled prescriptions(Average 2)
1Providers seen
92%Follow-up scheduled rate
50%Care coordination rate (with PCP)

Warning Signs visits with each kind

Controlled Medications 12 prescriptions, all Schedule II

Lisdexamfetamine 70 mg 3
Amphetamine-Dextroamphetamine 20 mg 3
Lisdexamfetamine 30 mg 3
Methylphenidate 10 mg 2
Methylphenidate 36 mg ER 1

Diagnoses 12 visits

12
  • ADHD, predominantly hyperactive type100%

Patient and Provider States 12 of 12 visits crossed state lines

NYPatient in New York
AZEddie Torreloma, NP in Arizona

0 of 12 visits were with a provider who has a license on record in New York.

Visit Checks

License to practice

0%

of Karen's visits were with a provider who has a license on record in New York.

Identity verified

83%

of Karen's visits have a record that the patient's identity was checked.

PDMP check rate

100%

of Karen's controlled prescriptions have a record that the state prescription database was checked first.

Check-in with other doctors

50%

of Karen's visits have a record of checking with the patient's regular doctor.

Follow-up scheduled

92%

of Karen's visits ended with a follow-up visit on the calendar.

Consent to treatment

100%

of Karen's visits have a record that the patient agreed to treatment.

Visit History

Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 30 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyJan 14, 2025
Telehealth visit with Eddie Torreloma, NP Methylphenidate 36 mg ER · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyNov 23, 2024
Telehealth visit with Eddie Torreloma, NP Methylphenidate 10 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyNov 15, 2024
Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 30 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyOct 29, 2024
Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 70 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicySep 28, 2024
Telehealth visit with Eddie Torreloma, NP Amphetamine-Dextroamphetamine 20 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicySep 7, 2024
Telehealth visit with Eddie Torreloma, NP Amphetamine-Dextroamphetamine 20 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyAug 30, 2024
Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 70 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyJul 7, 2024
Telehealth visit with Eddie Torreloma, NP Methylphenidate 10 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyMay 30, 2024
Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 30 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyMar 4, 2024
Office visit with Eddie Torreloma, NP Amphetamine-Dextroamphetamine 20 mg · Corporate Refill PolicyFeb 11, 2024
Telehealth visit with Eddie Torreloma, NP Lisdexamfetamine 70 mg · ID/Licensure Verification, Cross-State Licensure, Corporate Refill PolicyFeb 3, 2024
Showing the latest 10 of 12 visits